| INVEST study warns on too-low BP in diabetic patients with CAD. | |
| | |
MedLine Citation:
|
PMID: 20532441 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The INVEST (INternational VErapamil SR-Trandolapril) study, a very large international study of hypertensive patients, has shown that patients with type 2 diabetes and coronary artery disease do not benefit from tightening systolic blood pressure levels to below 130 mmHg, and this may in some cases be harmful. |
| | |
Authors:
|
J Aalbers |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Cardiovascular journal of Africa Volume: 21 ISSN: 1995-1892 ISO Abbreviation: Cardiovasc J Afr Publication Date: 2010 Mar-Apr |
Date Detail:
|
Created Date: 2010-06-09 Completed Date: 2010-07-29 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101313864 Medline TA: Cardiovasc J Afr Country: South Africa |
Other Details:
|
Languages: eng Pagination: 119 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antihypertensive Agents
/
administration & dosage*,
adverse effects Blood Pressure / physiology* Congresses as Topic Coronary Artery Disease / complications*, physiopathology Diabetes Mellitus / physiopathology* Dose-Response Relationship, Drug Humans Hypertension / complications, drug therapy*, physiopathology Practice Guidelines as Topic Randomized Controlled Trials as Topic Risk Factors |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: ACCORD LIPID study results strengthen guideline approach of adding fenofibrate to therapy of dyslipi...
Next Document: Combination therapy in hypertension: new recommendations.